Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

Understanding RSV: a significant threat for older adults this flu season ...

GSK's phase 3 trial shows Blenrep combined with BorDex improves overall survival in relapsed multiple myeloma.

Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...